177 related articles for article (PubMed ID: 34914779)
1. Studying how state health services delivery policies can mitigate the effects of disasters on drug addiction treatment and overdose: Protocol for a mixed-methods study.
Eisenberg MD; McCourt A; Stuart EA; Rutkow L; Tormohlen KN; Fingerhood MI; Quintero L; White SA; McGinty EE
PLoS One; 2021; 16(12):e0261115. PubMed ID: 34914779
[TBL] [Abstract][Full Text] [Related]
2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
3. Navigating addiction treatment during COVID-19: policy insights from state health leaders.
White SA; McCourt AD; Tormohlen KN; Yu J; Eisenberg MD; McGinty EE
Health Aff Sch; 2024 Feb; 2(2):qxae007. PubMed ID: 38344412
[TBL] [Abstract][Full Text] [Related]
4. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment.
Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR
Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469
[No Abstract] [Full Text] [Related]
5. Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.
Henderson R; McInnes A; Mackey L; Bruised Head M; Crowshoe L; Hann J; Hayward J; Holroyd BR; Lang E; Larson B; Leonard AJ; Persaud S; Raghavji K; Sarin C; Virani H; Wadsworth IW; Whitman S; McLane P
BMC Public Health; 2021 Jul; 21(1):1471. PubMed ID: 34320954
[TBL] [Abstract][Full Text] [Related]
6. Common themes in early state policy responses to substance use disorder treatment during COVID-19.
Andraka-Christou B; Bouskill K; Haffajee RL; Randall-Kosich O; Golan M; Totaram R; Gordon AJ; Stein BD
Am J Drug Alcohol Abuse; 2021 Jul; 47(4):486-496. PubMed ID: 33909518
[No Abstract] [Full Text] [Related]
7. Impact of the COVID-19 Pandemic on Child and Adolescent Mental Health Policy and Practice Implementation.
Palinkas LA; De Leon J; Salinas E; Chu S; Hunter K; Marshall TM; Tadehara E; Strnad CM; Purtle J; Horwitz SM; McKay MM; Hoagwood KE
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574547
[TBL] [Abstract][Full Text] [Related]
8. Increases in drug overdose deaths in Norway and the United States during the COVID-19 pandemic.
Friedman J; Gjersing L
Scand J Public Health; 2023 Feb; 51(1):53-57. PubMed ID: 35120430
[TBL] [Abstract][Full Text] [Related]
9. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
10. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
11. Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic.
Mannes ZL; Wheeler-Martin K; Terlizzi K; Hasin DS; Perry A; Pamplin JR; Crystal S; Cerdá M; Martins SS
Prev Med; 2023 Dec; 177():107789. PubMed ID: 38016582
[TBL] [Abstract][Full Text] [Related]
12. Increases in Naloxone Administrations by Emergency Medical Services Providers During the COVID-19 Pandemic: Retrospective Time Series Study.
Khoury D; Preiss A; Geiger P; Anwar M; Conway KP
JMIR Public Health Surveill; 2021 May; 7(5):e29298. PubMed ID: 33999828
[TBL] [Abstract][Full Text] [Related]
13. Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder.
Smart R; Grant S; Gordon AJ; Pacula RL; Stein BD
JAMA Health Forum; 2022 Sep; 3(9):e223285. PubMed ID: 36218944
[TBL] [Abstract][Full Text] [Related]
14. Medicaid prescription limits and their implications for naloxone accessibility.
Roberts AW; Look KA; Trull G; Carpenter DM
Drug Alcohol Depend; 2021 Jan; 218():108355. PubMed ID: 33309522
[TBL] [Abstract][Full Text] [Related]
15. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL; Macmadu A
Harm Reduct J; 2023 Feb; 20(1):14. PubMed ID: 36739417
[TBL] [Abstract][Full Text] [Related]
16. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
[TBL] [Abstract][Full Text] [Related]
17. PERSPECTIVE: Current US COVID-19 Pandemic Substance Use Research and Ideas for Research That May Help Us Learn More.
Duffy SQ
J Ment Health Policy Econ; 2021 Dec; 24(4):125-135. PubMed ID: 34907902
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and implementability of state-level naloxone access policies: Expert consensus from an online modified-Delphi process.
Smart R; Grant S
Int J Drug Policy; 2021 Dec; 98():103383. PubMed ID: 34340167
[TBL] [Abstract][Full Text] [Related]
19. Local health departments and the implementation of evidence-based policies to address opioid overdose mortality.
Feuerstein-Simon R; Lowenstein M; Sharma M; Dupuis R; Luna Marti X; Cannuscio CC
Subst Abus; 2020; 41(4):468-474. PubMed ID: 32213045
[TBL] [Abstract][Full Text] [Related]
20. Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators.
O'Malley DM; Abraham CM; Lee HS; Rubinstein EB; Howard J; Hudson SV; Kieber-Emmons AM; Crabtree BF
Fam Pract; 2022 Mar; 39(2):282-291. PubMed ID: 34423366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
